Novel vaccine composition for the treatment of respiratory infectious diseases

The present invention relates to a composition comprising a microencapsulated antigen having a native conformational epitope, particularly an antigen derived from the G protein of the human respiratory syncytial virus (RSV) encapsulated in poly(D,L-lactide-co-glycolide) copolymers (PLGA) microsphere...

Full description

Saved in:
Bibliographic Details
Main Authors ASIN, MIGUEL ANGEL, LIBON, CHRISTINE, HURTADO, PEPI, PEREZ, AMADEO, NGUYEN, NGOC THIEN, FERRET, EULALIA
Format Patent
LanguageEnglish
French
German
Published 24.09.2008
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a composition comprising a microencapsulated antigen having a native conformational epitope, particularly an antigen derived from the G protein of the human respiratory syncytial virus (RSV) encapsulated in poly(D,L-lactide-co-glycolide) copolymers (PLGA) microspheres. The present invention further relates to a method for producing such a composition and the use of these compositions for the preparation of a vaccine or immunogenic composition intended for the prevention or the treatment of RSV infection in mammals.
Bibliography:Application Number: EP20070290319